We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2377:TWSEMicro-Star International Co., Ltd. Analysis

Data as of 2026-03-16 - not real-time

NT$94.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Micro-Star International trades at TWD 94, sitting just above the 20‑day SMA of 93.07 but below the 50‑day SMA of 95.32, indicating a short‑term bearish bias. The RSI of 49.3 suggests neutral momentum, while the MACD histogram is positive (0.20) despite the MACD line remaining below its signal, hinting at a tentative technical recovery. Volatility is elevated at 30.95 % over the past 30 days and beta is modest (0.887), reflecting a stock that moves sharply but is not overly correlated with the market. Fundamentally, the stock appears undervalued – the DCF fair value of 96.92 is above the current price, offering roughly a 20 % upside, and the forward PE of 10.1 is well below the industry average PE of 33.7. The dividend yield of 5.39 % is attractive, yet a free‑cash‑flow deficit and a high payout ratio (~93 %) raise sustainability concerns. Overall, the company shows solid revenue growth (≈12 %) and a low price‑to‑sales multiple (0.345), but the bearish technical backdrop and cash‑flow strain temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 50‑day SMA indicating bearish bias
  • Neutral RSI and modest MACD bullish histogram
  • High 30‑day volatility and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests ~20 % upside
  • Forward PE of 10.1 versus industry PE of 33.7
  • Attractive dividend yield despite cash‑flow concerns

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strategic diversification into AIoT and gaming peripherals
  • Sustained high payout ratio may pressure dividend sustainability
  • Geopolitical exposure in Taiwan adds long‑run uncertainty

Key Metrics & Analysis

Financial Health

Revenue Growth11.90%
Profit Margin2.50%
P/E Ratio17.4
ROE10.70%
ROA3.67%
Debt/Equity21.43
P/B Ratio1.5
Op. Cash FlowNT$4.0B
Free Cash FlowNT$-799224640
Industry P/E33.7

Technical Analysis

TrendBearish
RSI49.3
SupportNT$87.60
ResistanceNT$99.80
MA 20NT$93.07
MA 50NT$95.32
MA 200NT$118.44
MACDBullish
VolumeDecreasing
Fear & Greed Index75.93

Valuation

Fair ValueNT$96.92
Target PriceNT$113.33
Upside/Downside20.57%
GradeUndervalued
TypeBlend
Dividend Yield5.39%

Risk Assessment

Beta0.89
Volatility30.95%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.